Gene · 7170
Papers3,595
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,595
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinct activation mechanisms regulate subtype selectivity of Cannabinoid receptors. | Commun Biol | 2023 | 37147497 | PubTator, text mining | PubMed |
| Oligomeric scaffolding for curvature generation by ER tubule-forming proteins. | Nat Commun | 2023 | 37147312 | PubTator, text mining | PubMed |
| Approach to risk stratification for papillary thyroid carcinoma based on molecular profiling: institutional analysis. | BJS Open | 2023 | 37146205 | PubTator, text mining | PubMed |
| Elaboration of NTRK-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant. | Dig Liver Dis | 2023 | 37142453 | PubTator, text mining | PubMed |
| Contents in tumor-educated platelets as the novel biosource for cancer diagnostics. | Front Oncol | 2023 | 37139159 | PubTator, text mining | PubMed |
| Structural basis for catalysis of human choline/ethanolamine phosphotransferase 1. | Nat Commun | 2023 | 37137909 | PubTator, text mining | PubMed |
| G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. | Signal Transduct Target Ther | 2023 | 37137892 | PubTator, text mining | PubMed |
| Molecular and clinical features of papillary thyroid cancer in adult patients with a non-classical phenotype. | Front Endocrinol (Lausanne) | 2023 | 37124750 | PubTator, text mining | PubMed |
| Entrectinib use in a platinum-refractory mucinous ovarian cancer harboring a NTRK3 gene fusion. | Gynecol Oncol Rep | 2023 | 37122438 | PubTator, text mining | PubMed |
| Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer. | Pharmaceutics | 2023 | 37111737 | PubTator, text mining | PubMed |
| [Clinicopathological features of gastric carcinomas with NTRK-rearrangement/amplification: report of four cases]. | Zhonghua Bing Li Xue Za Zhi | 2023 | 37106286 | PubTator, text mining | PubMed |
| Proteomics-Based Identification of Dysregulated Proteins and Biomarker Discovery in Invasive Ductal Carcinoma, the Most Common Breast Cancer Subtype. | Proteomes | 2023 | 37092454 | PubTator, text mining | PubMed |
| Identification of Serum miR-501-3p and miR-338-3p as Novel Diagnostic Biomarkers for Breast Cancer and Their Target Genes Associated with Immune Infiltration. | Int J Gen Med | 2023 | 37077765 | PubTator, text mining | PubMed |
| LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients. | Neuro Oncol | 2023 | 37075810 | PubTator, text mining | PubMed |
| Comparison of NTRK fusion detection methods in microsatellite-instability-high metastatic colorectal cancer. | Virchows Arch | 2023 | 37067589 | PubTator, text mining | PubMed |
| Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications. | Clin Cancer Res | 2023 | 37061987 | PubTator, text mining | PubMed |
| Natural history and treatment efficacy in an ambispective case series of NTRK-rearranged mesenchymal tumors. | ESMO Open | 2023 | 37054503 | PubTator, text mining | PubMed |
| Emerging Targeted Therapeutic Strategies to Overcome Imatinib Resistance of Gastrointestinal Stromal Tumors. | Int J Mol Sci | 2023 | 37046997 | PubTator, text mining | PubMed |
| TrkA Co-Receptors: The Janus Face of TrkA? | Cancers (Basel) | 2023 | 37046604 | PubTator, text mining | PubMed |
| Transmembrane protein CD69 acts as an S1PR1 agonist. | Elife | 2023 | 37039481 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7170/papers?page=20